Indication

Retinoblastoma

Retinoblastoma is a rare, malignant intraocular tumor that originates in the neurosensory layers of the developing retina. Read more about Retinoblastoma

31 drugs 30 manufacturers

Advertisement

Drugs that treat it

Common Retinoblastoma therapies.

Showing 19–27 of 31 drugs

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
ALEMBIC PHARMAC

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
ATHENEX PHARMAC

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
LONG GROVE PHAR

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
X-GEN PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Retinoblastoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Retinoblastoma.

Retinoblastoma is a rare, malignant intraocular tumor that originates in the neurosensory layers of the developing retina.

Primarily affecting infants and young children under five years of age, it arises from inactivating mutations in both alleles of the *RB1* tumor suppressor gene, occurring either as a germline, heritable form that frequently presents bilaterally or as a somatic, non-heritable form that typically presents unilaterally.

Hallmark clinical manifestations include leukocoria, characterized by an abnormal white pupillary reflex, and strabismus, with advanced or untreated cases potentially progressing to painful secondary glaucoma, orbital invasion, and intracranial or distant metastasis.

Personalize your experience

Follow Retinoblastoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it